(Q34134992)

31 July 2017

Synthesis and spectrum of the neoglycoside ACHN-490 (English)

1 reference

31 July 2017

5

Martin S Linsell

1 reference

31 July 2017

James B Aggen

1

1 reference

31 July 2017

Eliana S Armstrong

2

1 reference

31 July 2017

Adam A Goldblum

3

1 reference

31 July 2017

Paola Dozzo

4

1 reference

31 July 2017

Micah J Gliedt

6

1 reference

31 July 2017

Darin J Hildebrandt

7

1 reference

31 July 2017

Lee Ann Feeney

8

1 reference

31 July 2017

Aya Kubo

9

1 reference

31 July 2017

Rowena D Matias

10

1 reference

31 July 2017

Sara Lopez

11

1 reference

31 July 2017

Marcela Gomez

12

1 reference

31 July 2017

Kenneth B Wlasichuk

13

1 reference

31 July 2017

Raymond Diokno

14

1 reference

31 July 2017

George H Miller

15

1 reference

31 July 2017

Heinz E Moser

16

1 reference

31 July 2017

language of work or name

English

0 references

publication date

30 August 2010

1 reference

Antimicrobial Agents and Chemotherapy

31 July 2017

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

31 July 2017

54

1 reference

31 July 2017

11

1 reference

31 July 2017

4636-4642

1 reference

The changing epidemiology of resistance

31 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Molecular understanding of aminoglycoside action and resistance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Aminoglycoside-modifying enzymes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Combination antimicrobial therapy for bacterial infections. Guidelines for the clinician

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Clinical Significance of In Vitro Synergism Between Antibiotics in Gram-Negative Infections

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Chemotherapeutic Evaluation of 5-Episisomicin (Sch 22591), a New Semisynthetic Aminoglycoside

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

In vitro susceptibilities of aerobic and facultative anaerobic Gram-negative bacilli from patients with intra-abdominal infections worldwide from 2005-2007: results from the SMART study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Back to the future: using aminoglycosides again and how to dose them optimally

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Aminoglycoside antibiotics: old drugs and new therapeutic approaches

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

In vitro susceptibilities of aerobic and facultatively anaerobic Gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: 2004 results from SMART (Study for Monitoring Antimicrobial Resistance Trends).

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Contribution of the MexXY Multidrug Transporter to Aminoglycoside Resistance in Pseudomonas aeruginosa Clinical Isolates

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

Spectrum and activity of three contemporary fluoroquinolones tested against Pseudomonas aeruginosa isolates from urinary tract infections in the SENTRY Antimicrobial Surveillance Program (Europe and the Americas; 2000): more alike than different!

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2976124

The most frequently occurring aminoglycoside resistance mechanisms--combined results of surveys in eight regions of the world. The Aminoglycoside Resistance Study Groups

28 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20805391

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00572-10

1 reference

31 July 2017

1 reference

31 July 2017

1 reference